{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T03:18:34Z","timestamp":1788578314230,"version":"build-2803163510"},"reference-count":126,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T00:00:00Z","timestamp":1755820800000},"content-version":"vor","delay-in-days":52,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100024811","name":"Nuffield Department of Population Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100024811","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000769","name":"University of Oxford","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000769","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["FS\/ICRF\/22\/26039"],"award-info":[{"award-number":["FS\/ICRF\/22\/26039"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Aims<\/jats:title>\n                  <jats:p>The role of echocardiography in amyloidosis prognostication remains undefined in international guidelines. This meta-analysis aims to evaluate associations between echocardiography-derived measurements and clinical outcomes in light chain (AL) and transthyretin (ATTR) amyloidosis.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods and results<\/jats:title>\n                  <jats:p>MEDLINE, Embase, Cochrane Library, and Google Scholar were systematically searched through July 2024 for studies reporting associations between echocardiographic variables [left ventricular global longitudinal strain (LV-GLS), LV ejection fraction (LVEF), tricuspid annular plane systolic excursion (TAPSE), interventricular septum diameter (IVSd), LV mass index (LVMi) and E\/e\u2032 ratios] and adverse events in AL or ATTR amyloidosis. Prespecified demographic items and clinical outcomes were extracted by two blinded, independent reviewers. The prespecified primary outcome was all-cause mortality. Random-effect models were applied to pool hazard ratios (HR). 94 studies comprising 16158 patients (n = 4788 AL, n = 8241 ATTR, n = 3129 mixed aetiologies) were included. Median follow-up was 22.3 (IQR, 16.9\u201331.4) months. Higher all-cause mortality risk (HR, 1.10: 95%CI, 1.08\u20131.12; P &amp;lt; 0.001) was observed per 1% LV-GLS decrement, consistent across AL and ATTR subgroups. Lower all-cause mortality risk was seen with increasing LVEF (per 1%) and TAPSE (per 1\u2005mm) in the overall population (HRLVEF, 0.98; 95%CI, 0.98\u20130.98; P &amp;lt; 0.001; and HRTAPSE, 0.94; 95%CI, 0.93\u20130.95; P &amp;lt; 0.001) and in AL and ATTR subgroups. Higher E\/e\u2032 ratios (per 1 unit) were associated with all-cause mortality (HR, 1.02; 95%CI, 1.02\u20131.03; P &amp;lt; 0.001), consistent across AL and ATTR subtypes. No reliable associations between structural parameters (IVSd, LVMi) and clinical outcomes were found.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Echocardiographic measures of biventricular deformation, systolic and diastolic function, were consistently associated with mortality in amyloidosis, while structural parameters were not. Echocardiography may have an important role in the initial risk stratification of cardiac amyloidosis.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ehjopen\/oeaf078","type":"journal-article","created":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T07:55:10Z","timestamp":1750233310000},"source":"Crossref","is-referenced-by-count":1,"title":["Echocardiographic risk stratification in light chain and transthyretin amyloidosis: a meta-analysis"],"prefix":"10.1093","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8475-2861","authenticated-orcid":false,"given":"David","family":"Koeckerling","sequence":"first","affiliation":[{"name":"Department of Cardiology, Angiology and Pulmonology, Heidelberg University Hospital , Im Neuenheimer Feld 410, 69120 Heidelberg ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohin K","family":"Reddy","sequence":"additional","affiliation":[{"name":"National Heart and Lung Institute, Imperial College London , Dovehouse Street, London SW36LY ,","place":["UK"]},{"name":"Nuffield Department of Population Health, University of Oxford , Old Road Campus, Oxford OX37LF ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Eichhorn","sequence":"additional","affiliation":[{"name":"Harvard T.H. Chan School of Public Health, Huntington Avenue, Boston, MA 02115 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Volker","family":"Braun","sequence":"additional","affiliation":[{"name":"Medical Faculty Mannheim, University of Heidelberg , Ludolf-Krehl-Strasse, 68167 Mannheim ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yousif","family":"Ahmad","sequence":"additional","affiliation":[{"name":"Division of Cardiology, University of California , Parnassus Avenue, San Francisco, CA 94143 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James P","family":"Howard","sequence":"additional","affiliation":[{"name":"National Heart and Lung Institute, Imperial College London , Dovehouse Street, London SW36LY ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabian","family":"aus dem Siepen","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Angiology and Pulmonology, Heidelberg University Hospital , Im Neuenheimer Feld 410, 69120 Heidelberg ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0741-2633","authenticated-orcid":false,"given":"Benjamin","family":"Meder","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Angiology and Pulmonology, Heidelberg University Hospital , Im Neuenheimer Feld 410, 69120 Heidelberg ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbert","family":"Frey","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Angiology and Pulmonology, Heidelberg University Hospital , Im Neuenheimer Feld 410, 69120 Heidelberg ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derliz","family":"Mereles","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Angiology and Pulmonology, Heidelberg University Hospital , Im Neuenheimer Feld 410, 69120 Heidelberg ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,8,22]]},"reference":[{"key":"2025082120022600800_oeaf078-B1","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.jacc.2022.11.022","article-title":"2023 ACC expert consensus decision pathway on comprehensive multidisciplinary care for the patient with cardiac amyloidosis","volume":"81","author":"Kittleson","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"2025082120022600800_oeaf078-B2","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.jaccao.2022.08.009","article-title":"AL Amyloidosis for cardiologists","volume":"4","author":"Wechalekar","year":"2022","journal-title":"JACC CardioOncol"},{"key":"2025082120022600800_oeaf078-B3","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1016\/j.jcmg.2019.07.015","article-title":"How to image cardiac amyloidosis","volume":"13","author":"Dorbala","year":"2020","journal-title":"JACC Cardiovasc Imaging"},{"key":"2025082120022600800_oeaf078-B4","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1093\/eurheartj\/ehac259","article-title":"Characteristics and natural history of early-stage cardiac transthyretin amyloidosis","volume":"43","author":"Law","year":"2022","journal-title":"Eur Heart J"},{"key":"2025082120022600800_oeaf078-B5","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1161\/CIRCULATIONAHA.118.038169","article-title":"Natural history, quality of life, and outcome in cardiac transthyretin amyloidosis","volume":"140","author":"Lane","year":"2019","journal-title":"Circulation"},{"key":"2025082120022600800_oeaf078-B6","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1056\/NEJMoa2028631","article-title":"Daratumumab-based treatment for immunoglobulin light-chain amyloidosis","volume":"385","author":"Kastritis","year":"2021","journal-title":"N Engl J Med"},{"key":"2025082120022600800_oeaf078-B7","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1056\/NEJMoa1805689","article-title":"Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy","volume":"379","author":"Maurer","year":"2018","journal-title":"N Engl J Med"},{"key":"2025082120022600800_oeaf078-B8","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1056\/NEJMoa2305434","article-title":"Efficacy and safety of acoramidis in transthyretin amyloid cardiomyopathy","volume":"390","author":"Gillmore","year":"2024","journal-title":"N Engl J Med"},{"key":"2025082120022600800_oeaf078-B9","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1001\/jama.2020.5493","article-title":"Systemic amyloidosis recognition, prognosis, and therapy: a systematic review","volume":"324","author":"Gertz","year":"2020","journal-title":"JAMA"},{"key":"2025082120022600800_oeaf078-B10","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1001\/jama.2024.13946","article-title":"Risk stratification in nonischemic dilated cardiomyopathy using cardiac magnetic resonance imaging: a systematic review and meta-analysis","volume":"332","author":"Eichhorn","year":"2024","journal-title":"JAMA"},{"key":"2025082120022600800_oeaf078-B11","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1161\/CIR.0000000000000792","article-title":"Cardiac amyloidosis: evolving diagnosis and management: a scientific statement from the American Heart Association","volume":"142","author":"Kittleson","year":"2020","journal-title":"Circulation"},{"key":"2025082120022600800_oeaf078-B12","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1093\/eurheartj\/ehab072","article-title":"Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases","volume":"42","author":"Garcia-Pavia","year":"2021","journal-title":"Eur Heart J"},{"key":"2025082120022600800_oeaf078-B13","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/j.jacc.2022.01.036","article-title":"Critical comparison of documents from scientific societies on cardiac amyloidosis","volume":"79","author":"Rapezzi","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"2025082120022600800_oeaf078-B14","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1001\/jamasurg.2021.0522","article-title":"MOOSE reporting guidelines for meta-analyses of observational studies","volume":"156","author":"Brooke","year":"2021","journal-title":"JAMA Surg"},{"key":"2025082120022600800_oeaf078-B15","doi-asserted-by":"crossref","first-page":"280","DOI":"10.7326\/0003-4819-158-4-201302190-00009","article-title":"Assessing bias in studies of prognostic factors","volume":"158","author":"Hayden","year":"2013","journal-title":"Ann Intern Med"},{"key":"2025082120022600800_oeaf078-B16","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions","author":"Chandler","year":"2019"},{"key":"2025082120022600800_oeaf078-B17","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1471-2288-14-25","article-title":"The Hartung-Knapp-Sidik-Jonkman method for random effects meta-analysis is straightforward and considerably outperforms the standard DerSimonian-Laird method","volume":"14","author":"IntHout","year":"2014","journal-title":"BMC Med Res Methodol"},{"key":"2025082120022600800_oeaf078-B18","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1016\/j.amjcard.2017.08.024","article-title":"Predictors of prognosis in light-chain amyloidosis and chronological changes in cardiac morphology and function","volume":"120","author":"Amano","year":"2017","journal-title":"Am J Cardiol"},{"key":"2025082120022600800_oeaf078-B19","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1016\/j.amjcard.2012.05.061","article-title":"Clinical and echocardiographic correlates of elevated troponin in amyloid light-chain cardiac amyloidosis","volume":"110","author":"Apridonidze","year":"2012","journal-title":"Am J Cardiol"},{"key":"2025082120022600800_oeaf078-B20","doi-asserted-by":"crossref","first-page":"e002310","DOI":"10.1136\/openhrt-2023-002310","article-title":"Prognosis of light chain amyloidosis: a multivariable analysis for survival prediction in patients with cardiac involvement proven by endomyocardial biopsy","volume":"10","author":"Aurich","year":"2023","journal-title":"Open Heart"},{"key":"2025082120022600800_oeaf078-B21","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1007\/s00392-017-1167-1","article-title":"Predictors of survival stratification in patients with wild-type cardiac amyloidosis","volume":"107","author":"Siepen","year":"2018","journal-title":"Clin Res Cardiol"},{"key":"2025082120022600800_oeaf078-B22","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/j.amjcard.2009.01.361","article-title":"Comparison of functional status, electrocardiographic, and echocardiographic parameters to mortality in endomyocardial-biopsy proven cardiac amyloidosis","volume":"103","author":"Austin","year":"2009","journal-title":"Am J Cardiol"},{"key":"2025082120022600800_oeaf078-B23","doi-asserted-by":"crossref","first-page":"904878","DOI":"10.3389\/fcvm.2022.904878","article-title":"Prognostic implication of longitudinal changes of left ventricular global strain after chemotherapy in cardiac light chain amyloidosis","volume":"9","author":"Bak","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"2025082120022600800_oeaf078-B24","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s12471-017-1046-4","article-title":"Role of cardiovascular magnetic resonance in suspected cardiac amyloidosis: late gadolinium enhancement pattern as mortality predictor","volume":"26","author":"Baroni","year":"2018","journal-title":"Neth Heart J"},{"key":"2025082120022600800_oeaf078-B25","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.jcmg.2016.04.008","article-title":"Prognosis of light chain amyloidosis with preserved LVEF: added value of 2D speckle-tracking echocardiography to the current prognostic staging system","volume":"10","author":"Barros-Gomes","year":"2017","journal-title":"JACC Cardiovasc Imaging"},{"key":"2025082120022600800_oeaf078-B26","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/ehjci\/jey225","article-title":"Mechanisms of heart failure in transthyretin vs. light chain amyloidosis","volume":"20","author":"Binder","year":"2019","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2025082120022600800_oeaf078-B27","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1080\/13506129.2016.1194264","article-title":"Prognostic value of right ventricular systolic function in cardiac amyloidosis","volume":"23","author":"Bodez","year":"2016","journal-title":"Amyloid"},{"key":"2025082120022600800_oeaf078-B28","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.jcmg.2015.10.027","article-title":"LGE provides incremental prognostic information over serum biomarkers in AL cardiac amyloidosis","volume":"9","author":"Boynton","year":"2016","journal-title":"JACC Cardiovasc Imaging"},{"key":"2025082120022600800_oeaf078-B29","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.jacc.2012.04.043","article-title":"Longitudinal left ventricular function for prediction of survival in systemic light-chain amyloidosis: incremental value compared with clinical and biochemical markers","volume":"60","author":"Buss","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"2025082120022600800_oeaf078-B30","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s11739-016-1500-0","article-title":"Liver dysfunction as predictor of prognosis in patients with amyloidosis: utility of the Model for End-stage Liver disease (MELD) scoring system","volume":"12","author":"Cappelli","year":"2017","journal-title":"Intern Emerg Med"},{"key":"2025082120022600800_oeaf078-B31","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1093\/ejechocard\/jer289","article-title":"Right ventricular function in AL amyloidosis: characteristics and prognostic implication","volume":"13","author":"Cappelli","year":"2012","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2025082120022600800_oeaf078-B32","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1093\/eurheartj\/ehz905","article-title":"Echocardiographic phenotype and prognosis in transthyretin cardiac amyloidosis","volume":"41","author":"Chacko","year":"2020","journal-title":"Eur Heart J"},{"key":"2025082120022600800_oeaf078-B33","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.jaccao.2022.08.007","article-title":"Low QRS voltages in cardiac amyloidosis: clinical correlates and prognostic value","volume":"4","author":"Cipriani","year":"2022","journal-title":"JACC CardioOncol"},{"key":"2025082120022600800_oeaf078-B34","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1093\/eurheartj\/ehab507","article-title":"Longitudinal strain is an independent predictor of survival and response to therapy in patients with systemic AL amyloidosis","volume":"43","author":"Cohen","year":"2022","journal-title":"Eur Heart J"},{"key":"2025082120022600800_oeaf078-B35","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3390\/cardiogenetics12020017","article-title":"Modified body mass index as a novel nutritional and prognostic marker in patients with cardiac amyloidosis","volume":"12","author":"Dongiglio","year":"2022","journal-title":"Cardiogenetics"},{"key":"2025082120022600800_oeaf078-B36","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.recesp.2020.10.001","article-title":"Prognostic value of right ventricular function in light-chain cardiac amyloidosis treated with bortezomib","volume":"74","author":"Durante-L\u00f3pez","year":"2021","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"key":"2025082120022600800_oeaf078-B37","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s00392-019-01490-2","article-title":"When and how do patients with cardiac amyloidosis die?","volume":"109","author":"Escher","year":"2020","journal-title":"Clin Res Cardiol"},{"key":"2025082120022600800_oeaf078-B38","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1002\/ehf2.13093","article-title":"Impact of tricuspid regurgitation on survival in patients with cardiac amyloidosis","volume":"8","author":"Fagot","year":"2021","journal-title":"ESC Heart Fail"},{"key":"2025082120022600800_oeaf078-B39","first-page":"432","article-title":"Determinants and prognostic significance of serial right heart function changes in patients with cardiac amyloidosis","volume":"36","author":"Fine","year":"2020","journal-title":"Can J Cardiol"},{"key":"2025082120022600800_oeaf078-B40","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1161\/CIRCULATIONAHA.115.016567","article-title":"Prognostic value of late gadolinium enhancement cardiovascular magnetic resonance in cardiac amyloidosis","volume":"132","author":"Fontana","year":"2015","journal-title":"Circulation"},{"key":"2025082120022600800_oeaf078-B41","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1016\/j.mayocp.2021.04.021","article-title":"Early diagnosis and outcome in patients with wild-type transthyretin cardiac amyloidosis","volume":"96","author":"Fumagalli","year":"2021","journal-title":"Mayo Clin Proc"},{"key":"2025082120022600800_oeaf078-B42","doi-asserted-by":"crossref","first-page":"210","DOI":"10.3109\/13506129.2015.1072089","article-title":"Usefulness of (99m)Tc-HMDP scintigraphy for the etiologic diagnosis and prognosis of cardiac amyloidosis","volume":"22","author":"Galat","year":"2015","journal-title":"Amyloid"},{"key":"2025082120022600800_oeaf078-B43","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.ijcard.2016.07.254","article-title":"Outcome and incidence of appropriate implantable cardioverter-defibrillator therapy in patients with cardiac amyloidosis","volume":"222","author":"Hamon","year":"2016","journal-title":"Int J Cardiol"},{"key":"2025082120022600800_oeaf078-B44","doi-asserted-by":"crossref","first-page":"e004000","DOI":"10.1161\/CIRCHEARTFAILURE.117.004000","article-title":"Use of serum transthyretin as a prognostic indicator and predictor of outcome in cardiac amyloid disease associated with wild-type transthyretin","volume":"11","author":"Hanson","year":"2018","journal-title":"Circ Heart Fail"},{"key":"2025082120022600800_oeaf078-B45","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1080\/13506129.2018.1496077","article-title":"Peak V'O(2) is an independent predictor of survival in patients with cardiac amyloidosis","volume":"25","author":"Hein","year":"2018","journal-title":"Amyloid"},{"key":"2025082120022600800_oeaf078-B46","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1007\/s10554-015-0711-1","article-title":"Impact of monitoring longitudinal systolic strain changes during serial echocardiography on outcome in patients with AL amyloidosis","volume":"31","author":"Hu","year":"2015","journal-title":"Int J Cardiovasc Imaging"},{"key":"2025082120022600800_oeaf078-B47","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1093\/ehjci\/jeaa146","article-title":"Time trajectory of cardiac function and its relation with survival in patients with light-chain cardiac amyloidosis","volume":"22","author":"Hwang","year":"2021","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2025082120022600800_oeaf078-B48","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1080\/00365513.2024.2346908","article-title":"Clinical and imaging characteristics of patients with cardiac amyloidosis - a single center observational study","volume":"84","author":"Ingebrigtsen","year":"2024","journal-title":"Scand J Clin Lab Invest"},{"key":"2025082120022600800_oeaf078-B49","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jelectrocard.2021.08.011","article-title":"Electrocardiographic left ventricular strain pattern, ST-segment depression and atrial fibrillation at the time of diagnosis of systemic light chain amyloidosis: incidence and clinical significance","volume":"68","author":"Jakait\u0117","year":"2021","journal-title":"J Electrocardiol"},{"key":"2025082120022600800_oeaf078-B50","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.echo.2016.07.017","article-title":"Cumulative burden of myocardial dysfunction in cardiac amyloidosis assessed using four-chamber cardiac strain","volume":"29","author":"Kado","year":"2016","journal-title":"J Am Soc Echocardiogr"},{"key":"2025082120022600800_oeaf078-B51","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1002\/ehf2.13131","article-title":"Prevalence and prognostic value of autonomic neuropathy assessed by Sudoscan\u00ae in transthyretin wild-type cardiac amyloidosis","volume":"8","author":"Kharoubi","year":"2021","journal-title":"ESC Heart Fail"},{"key":"2025082120022600800_oeaf078-B52","doi-asserted-by":"crossref","first-page":"5594","DOI":"10.1002\/ehf2.13604","article-title":"Clinical and prognostic implications of capillary density in patients with cardiac light chain amyloidosis","volume":"8","author":"Kim","year":"2021","journal-title":"ESC Heart Fail"},{"key":"2025082120022600800_oeaf078-B53","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jjcc.2023.04.019","article-title":"Clinical characteristics and prognostic implications of orthopedic ligament disorders in patients with wild-type transthyretin amyloidosis cardiomyopathy","volume":"82","author":"Klarskov","year":"2023","journal-title":"J Cardiol"},{"key":"2025082120022600800_oeaf078-B54","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.jcmg.2018.02.016","article-title":"Cardiac structural and functional consequences of amyloid deposition by cardiac magnetic resonance and echocardiography and their prognostic roles","volume":"12","author":"Knight","year":"2019","journal-title":"JACC Cardiovasc Imaging"},{"key":"2025082120022600800_oeaf078-B55","doi-asserted-by":"crossref","first-page":"1073804","DOI":"10.3389\/fcvm.2022.1073804","article-title":"Evaluation of contemporary echocardiographic and histomorphology parameters in predicting mortality in patients with endomyocardial biopsy-proven cardiac AL amyloidosis","volume":"9","author":"Koutroumpakis","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"2025082120022600800_oeaf078-B56","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jacc.2016.04.035","article-title":"Cardiac amyloid load: a prognostic and predictive biomarker in patients with light-chain amyloidosis","volume":"68","author":"Kristen","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"2025082120022600800_oeaf078-B57","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.jcmg.2014.03.002","article-title":"Noninvasive risk stratification of patients with transthyretin amyloidosis","volume":"7","author":"Kristen","year":"2014","journal-title":"JACC Cardiovasc Imaging"},{"key":"2025082120022600800_oeaf078-B58","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1111\/echo.15681","article-title":"Strain-derived myocardial work in wild-type transthyretin cardiac amyloidosis with aortic stenosis-diagnosis and prognosis","volume":"40","author":"Ladefoged","year":"2023","journal-title":"Echocardiography"},{"key":"2025082120022600800_oeaf078-B59","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.jaccao.2020.05.012","article-title":"Incremental value of global longitudinal strain for predicting survival in patients with advanced AL amyloidosis","volume":"2","author":"Lee Chuy","year":"2020","journal-title":"JACC CardioOncol"},{"key":"2025082120022600800_oeaf078-B60","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.mayocp.2014.01.013","article-title":"Cardiac amyloidosis without increased left ventricular wall thickness","volume":"89","author":"Lee","year":"2014","journal-title":"Mayo Clin Proc"},{"key":"2025082120022600800_oeaf078-B61","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.jaccao.2020.09.002","article-title":"Assessment of left ventricular, right ventricular, and left atrial strain in light-chain amyloidosis","volume":"2","author":"Leedy","year":"2020","journal-title":"JACC CardioOncol"},{"key":"2025082120022600800_oeaf078-B62","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s12872-021-01856-3","article-title":"Predictors of cardiac involvement and survival in patients with primary systemic light-chain amyloidosis: roles of the clinical, chemical, and 3-D speckle tracking echocardiography parameters","volume":"21","author":"Lei","year":"2021","journal-title":"BMC Cardiovasc Disord"},{"key":"2025082120022600800_oeaf078-B63","first-page":"12","article-title":"Mid-basal left ventricular longitudinal dysfunction as a prognostic marker in mutated transthyretin-related cardiac amyloidosis","volume":"6","author":"Licordari","year":"2022","journal-title":"Vessel Plus"},{"key":"2025082120022600800_oeaf078-B64","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s12968-017-0419-6","article-title":"The prognostic value of T1 mapping and late gadolinium enhancement cardiovascular magnetic resonance imaging in patients with light chain amyloidosis","volume":"20","author":"Lin","year":"2018","journal-title":"J Cardiovasc Magn Reson"},{"key":"2025082120022600800_oeaf078-B65","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1007\/s10554-017-1075-5","article-title":"Value of tissue Doppler-derived Tei index and two-dimensional speckle tracking imaging derived longitudinal strain on predicting outcome of patients with light-chain cardiac amyloidosis","volume":"33","author":"Liu","year":"2017","journal-title":"Int J Cardiovasc Imaging"},{"key":"2025082120022600800_oeaf078-B66","doi-asserted-by":"crossref","first-page":"e115910","DOI":"10.1371\/journal.pone.0115910","article-title":"Predictive value of assessing diastolic strain rate on survival in cardiac amyloidosis patients with preserved ejection fraction","volume":"9","author":"Liu","year":"2014","journal-title":"PLoS One"},{"key":"2025082120022600800_oeaf078-B67","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1186\/s12872-022-02589-7","article-title":"Prognostic value of left atrial mechanics in cardiac light-chain amyloidosis with preserved ejection fraction: a cohort study","volume":"22","author":"Liu","year":"2022","journal-title":"BMC Cardiovasc Disord"},{"key":"2025082120022600800_oeaf078-B68","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3109\/13506129.2015.1028616","article-title":"Atrial fibrillation in amyloidotic cardiomyopathy: prevalence, incidence, risk factors and prognostic role","volume":"22","author":"Longhi","year":"2015","journal-title":"Amyloid"},{"key":"2025082120022600800_oeaf078-B69","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.recesp.2024.01.001","article-title":"Prognostic value of the tricuspid annular plane systolic excursion\/systolic pulmonary artery pressure ratio in cardiac amyloidosis","volume":"77","author":"Maccallini","year":"2024","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"key":"2025082120022600800_oeaf078-B70","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1016\/j.echo.2009.09.012","article-title":"Left ventricular ejection time on echocardiography predicts long-term mortality in light chain amyloidosis","volume":"22","author":"Migrino","year":"2009","journal-title":"J Am Soc Echocardiogr"},{"key":"2025082120022600800_oeaf078-B71","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s00392-016-1058-x","article-title":"Prevalence and prognostic impact of left-sided valve thickening in systemic light-chain amyloidosis","volume":"106","author":"Mohty","year":"2017","journal-title":"Clin Res Cardiol"},{"key":"2025082120022600800_oeaf078-B72","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.echo.2024.06.006","article-title":"Right ventricular strain improves the echocardiographic diagnosis and risk stratification of transthyretin cardiac amyloidosis among other phenotypes of left ventricular hypertrophy","volume":"37","author":"Ozbay","year":"2024","journal-title":"J Am Soc Echocardiogr"},{"key":"2025082120022600800_oeaf078-B73","doi-asserted-by":"crossref","first-page":"131147","DOI":"10.1016\/j.ijcard.2023.131147","article-title":"Prevalence and clinical significance of right ventricular pulmonary arterial uncoupling in cardiac amyloidosis","volume":"388","author":"Palmiero","year":"2023","journal-title":"Int J Cardiol"},{"key":"2025082120022600800_oeaf078-B74","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.rccl.2021.03.001","article-title":"Caracterizaci\u00f3n y pron\u00f3stico del paciente con amiloidosis cardiaca: experiencia de un centro","volume":"57","author":"Pericet-Rodr\u00edguez","year":"2022","journal-title":"REC CardioClinics"},{"key":"2025082120022600800_oeaf078-B75","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.echo.2019.04.418","article-title":"Myocardial stiffness by intrinsic cardiac elastography in patients with amyloidosis: comparison with chamber stiffness and global longitudinal strain","volume":"32","author":"Pislaru","year":"2019","journal-title":"J Am Soc Echocardiogr"},{"key":"2025082120022600800_oeaf078-B76","doi-asserted-by":"crossref","first-page":"1026440","DOI":"10.3389\/fcvm.2022.1026440","article-title":"Evolving trends in epidemiology and natural history of cardiac amyloidosis: 30-year experience from a tertiary referral center for cardiomyopathies","volume":"9","author":"Porcari","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"2025082120022600800_oeaf078-B77","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1161\/CIRCULATIONAHA.123.066524","article-title":"Clinical and prognostic implications of right ventricular uptake on bone scintigraphy in transthyretin amyloid cardiomyopathy","volume":"149","author":"Porcari","year":"2024","journal-title":"Circulation"},{"key":"2025082120022600800_oeaf078-B78","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/ejhf.2776","article-title":"Prevalence, characteristics and outcomes of older patients with hereditary versus wild-type transthyretin amyloid cardiomyopathy","volume":"25","author":"Porcari","year":"2023","journal-title":"Eur J Heart Fail"},{"key":"2025082120022600800_oeaf078-B79","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.echo.2017.08.017","article-title":"Prognostic and added value of two-dimensional global longitudinal strain for prediction of survival in patients with light chain amyloidosis undergoing autologous hematopoietic cell transplantation","volume":"31","author":"Pun","year":"2018","journal-title":"J Am Soc Echocardiogr"},{"key":"2025082120022600800_oeaf078-B80","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1161\/CIRCULATIONAHA.113.006242","article-title":"Left ventricular structure and function in transthyretin-related versus light-chain cardiac amyloidosis","volume":"129","author":"Quarta","year":"2014","journal-title":"Circulation"},{"key":"2025082120022600800_oeaf078-B81","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.jcmg.2011.03.016","article-title":"Role of (99m)Tc-DPD scintigraphy in diagnosis and prognosis of hereditary transthyretin-related cardiac amyloidosis","volume":"4","author":"Rapezzi","year":"2011","journal-title":"JACC Cardiovasc Imaging"},{"key":"2025082120022600800_oeaf078-B82","doi-asserted-by":"crossref","first-page":"e004769","DOI":"10.1161\/CIRCHEARTFAILURE.117.004769","article-title":"TTR (Transthyretin) stabilizers are associated with improved survival in patients with TTR cardiac amyloidosis","volume":"11","author":"Rosenblum","year":"2018","journal-title":"Circ Heart Fail"},{"key":"2025082120022600800_oeaf078-B83","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/ehf2.14545","article-title":"Outcome prediction by myocardial external efficiency from (11) C-acetate positron emission tomography in cardiac amyloidosis","volume":"11","author":"Rosengren","year":"2024","journal-title":"ESC Heart Fail"},{"key":"2025082120022600800_oeaf078-B84","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1136\/heartjnl-2015-308657","article-title":"Prognostic implication of relative regional strain ratio in cardiac amyloidosis","volume":"102","author":"Senapati","year":"2016","journal-title":"Heart"},{"key":"2025082120022600800_oeaf078-B85","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1080\/13506129.2021.2000388","article-title":"Diflunisal treatment is associated with improved survival for patients with early stage wild-type transthyretin (ATTR) amyloid cardiomyopathy: the Boston University Amyloidosis Center experience","volume":"29","author":"Siddiqi","year":"2022","journal-title":"Amyloid"},{"key":"2025082120022600800_oeaf078-B86","doi-asserted-by":"crossref","first-page":"102729","DOI":"10.1016\/j.cpcardiol.2024.102729","article-title":"Defining echocardiographic predictors of outcome in cardiac amyloidosis by subtype","volume":"49","author":"Singulane","year":"2024","journal-title":"Curr Probl Cardiol"},{"key":"2025082120022600800_oeaf078-B87","doi-asserted-by":"crossref","first-page":"e002877","DOI":"10.1161\/JAHA.115.002877","article-title":"Subtype-specific interactions and prognosis in cardiac amyloidosis","volume":"5","author":"Sperry","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"2025082120022600800_oeaf078-B88","first-page":"854","article-title":"Impaired right ventricular function as a predictor of early mortality in patients with light- chain cardiac amyloidosis assessed in a cardiology department","volume":"127","author":"Szczygie\u0142","year":"2017","journal-title":"Pol Arch Intern Med"},{"key":"2025082120022600800_oeaf078-B89","doi-asserted-by":"crossref","first-page":"8552","DOI":"10.1038\/s41598-019-44912-x","article-title":"Predictors of mortality in light chain cardiac amyloidosis with heart failure","volume":"9","author":"Tahir","year":"2019","journal-title":"Sci Rep"},{"key":"2025082120022600800_oeaf078-B90","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1002\/ehf2.14380","article-title":"Clinical characteristics, outcome, and therapeutic effect of tafamidis in wild-type transthyretin amyloid cardiomyopathy","volume":"10","author":"Takashio","year":"2023","journal-title":"ESC Heart Fail"},{"key":"2025082120022600800_oeaf078-B91","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1007\/s10554-022-02534-x","article-title":"Left atrial remodeling and the prognostic value of feature tracking derived left atrial strain in patients with light-chain amyloidosis: a cardiovascular magnetic resonance study","volume":"38","author":"Tan","year":"2022","journal-title":"Int J Cardiovasc Imaging"},{"key":"2025082120022600800_oeaf078-B92","doi-asserted-by":"crossref","first-page":"e005868","DOI":"10.1161\/JAHA.112.005868","article-title":"Circulating matrix metalloproteinases and tissue inhibitors of metalloproteinases in cardiac amyloidosis","volume":"2","author":"Tanaka","year":"2013","journal-title":"J Am Heart Assoc"},{"key":"2025082120022600800_oeaf078-B93","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3109\/13506129.2014.994202","article-title":"The myocardial contraction fraction is superior to ejection fraction in predicting survival in patients with AL cardiac amyloidosis","volume":"22","author":"Tendler","year":"2015","journal-title":"Amyloid"},{"key":"2025082120022600800_oeaf078-B94","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jcmg.2015.05.014","article-title":"Causes and consequences of longitudinal LV dysfunction assessed by 2D strain echocardiography in cardiac amyloidosis","volume":"9","author":"Ternacle","year":"2016","journal-title":"JACC Cardiovasc Imaging"},{"key":"2025082120022600800_oeaf078-B95","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.amjcard.2022.02.048","article-title":"Prognostic implications of right ventricular systolic dysfunction in cardiac amyloidosis","volume":"173","author":"Tjahjadi","year":"2022","journal-title":"Am J Cardiol"},{"key":"2025082120022600800_oeaf078-B96","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1093\/ehjci\/jead145","article-title":"Right ventricular to pulmonary artery coupling and outcome in patients with cardiac amyloidosis","volume":"24","author":"Tomasoni","year":"2023","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2025082120022600800_oeaf078-B97","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.1002\/ejhf.2616","article-title":"Value of the HFA-PEFF and H(2) FPEF scores in patients with heart failure and preserved ejection fraction caused by cardiac amyloidosis","volume":"24","author":"Tomasoni","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"2025082120022600800_oeaf078-B98","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jjcc.2022.02.010","article-title":"Prognostic value of right ventricular global longitudinal strain in transthyretin amyloid cardiomyopathy","volume":"80","author":"Usuku","year":"2022","journal-title":"J Cardiol"},{"key":"2025082120022600800_oeaf078-B99","doi-asserted-by":"crossref","first-page":"oead048","DOI":"10.1093\/ehjopen\/oead048","article-title":"Prognostic value of right ventricular global longitudinal strain in patients with immunoglobulin light-chain cardiac amyloidosis","volume":"3","author":"Usuku","year":"2023","journal-title":"Eur Heart J Open"},{"key":"2025082120022600800_oeaf078-B100","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1002\/ehf2.14710","article-title":"A new staging system using right atrial strain in patients with immunoglobulin light-chain cardiac amyloidosis","volume":"11","author":"Usuku","year":"2024","journal-title":"ESC Heart Fail"},{"key":"2025082120022600800_oeaf078-B101","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1080\/13506129.2017.1417121","article-title":"Right ventricular longitudinal strain: a tool for diagnosis and prognosis in light-chain amyloidosis","volume":"25","author":"Uzan","year":"2018","journal-title":"Amyloid"},{"key":"2025082120022600800_oeaf078-B102","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1007\/s12350-016-0768-9","article-title":"Technetium pyrophosphate uptake in transthyretin cardiac amyloidosis: associations with echocardiographic disease severity and outcomes","volume":"25","author":"Vranian","year":"2018","journal-title":"J Nucl Cardiol"},{"key":"2025082120022600800_oeaf078-B103","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.jaccao.2024.03.007","article-title":"Atrial fibrillation as a prognostic factor for all-cause mortality in patients with transthyretin amyloid cardiomyopathy","volume":"6","author":"Witteles","year":"2024","journal-title":"JACC CardioOncol"},{"key":"2025082120022600800_oeaf078-B104","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1159\/000527442","article-title":"Association of cancer antigen 125 with long-term prognosis in light-chain cardiorenal amyloidosis","volume":"13","author":"Wu","year":"2023","journal-title":"Cardiorenal Med"},{"key":"2025082120022600800_oeaf078-B105","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1186\/s12872-021-02256-3","article-title":"A real-world study on diagnosis and prognosis of light-chain cardiac amyloidosis in Southern China","volume":"21","author":"Wu","year":"2021","journal-title":"BMC Cardiovasc Disord"},{"key":"2025082120022600800_oeaf078-B106","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1002\/ehf2.12884","article-title":"Clinical characteristics and natural history of wild-type transthyretin amyloid cardiomyopathy in Japan","volume":"7","author":"Yamada","year":"2020","journal-title":"ESC Heart Fail"},{"key":"2025082120022600800_oeaf078-B107","doi-asserted-by":"crossref","first-page":"8415","DOI":"10.1007\/s00432-023-04783-2","article-title":"Echocardiographic phenotype for refined risk stratification and treatment selection in light chain amyloidosis with heart failure","volume":"149","author":"Yang","year":"2023","journal-title":"J Cancer Res Clin Oncol"},{"key":"2025082120022600800_oeaf078-B108","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ijcard.2021.12.048","article-title":"Sex-related differences in clinical presentation and all-cause mortality in patients with cardiac transthyretin amyloidosis and light chain amyloidosis","volume":"351","author":"Zampieri","year":"2022","journal-title":"Int J Cardiol"},{"key":"2025082120022600800_oeaf078-B109","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1002\/ehf2.14671","article-title":"Prognostic mortality factors in advanced light chain cardiac amyloidosis: a prospective cohort study","volume":"11","author":"Zaroui","year":"2024","journal-title":"ESC Heart Fail"},{"key":"2025082120022600800_oeaf078-B110","doi-asserted-by":"crossref","first-page":"3070017","DOI":"10.1155\/2023\/3070017","article-title":"Prognostic factors and survival of Chinese patients with cardiac amyloidosis","volume":"2023","author":"Zhang","year":"2023","journal-title":"Dis Markers"},{"key":"2025082120022600800_oeaf078-B111","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.amjms.2015.12.015","article-title":"Risk factors and prognostic role of left atrial enlargement in patients with cardiac light-chain amyloidosis","volume":"351","author":"Zhao","year":"2016","journal-title":"Am J Med Sci"},{"key":"2025082120022600800_oeaf078-B112","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.jcmg.2019.10.011","article-title":"Multiparametric echocardiography scores for the diagnosis of cardiac amyloidosis","volume":"13","author":"Boldrini","year":"2020","journal-title":"JACC Cardiovasc Imaging"},{"key":"2025082120022600800_oeaf078-B113","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.echo.2017.01.020","article-title":"Expert review on the prognostic role of echocardiography after acute myocardial infarction","volume":"30","author":"Prastaro","year":"2017","journal-title":"J Am Soc Echocardiogr"},{"key":"2025082120022600800_oeaf078-B114","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1161\/CIRCULATIONAHA.111.078915","article-title":"Transthyretin (TTR) cardiac amyloidosis","volume":"126","author":"Ruberg","year":"2012","journal-title":"Circulation"},{"key":"2025082120022600800_oeaf078-B115","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1161\/CIRCRESAHA.121.318187","article-title":"Pathophysiology and therapeutic approaches to cardiac amyloidosis","volume":"128","author":"Griffin","year":"2021","journal-title":"Circ Res"},{"key":"2025082120022600800_oeaf078-B116","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1161\/01.RES.0000126569.75419.74","article-title":"Human amyloidogenic light chains directly impair cardiomyocyte function through an increase in cellular oxidant stress","volume":"94","author":"Brenner","year":"2004","journal-title":"Circ Res"},{"key":"2025082120022600800_oeaf078-B117","doi-asserted-by":"crossref","first-page":"15661","DOI":"10.1038\/s41598-017-15424-3","article-title":"Proteotoxicity in cardiac amyloidosis: amyloidogenic light chains affect the levels of intracellular proteins in human heart cells","volume":"7","author":"Imperlini","year":"2017","journal-title":"Sci Rep"},{"key":"2025082120022600800_oeaf078-B118","doi-asserted-by":"crossref","first-page":"e00172","DOI":"10.1042\/BSR20140155","article-title":"Amyloidogenic and non-amyloidogenic transthyretin variants interact differently with human cardiomyocytes: insights into early events of non-fibrillar tissue damage","volume":"35","author":"Manral","year":"2015","journal-title":"Biosci Rep"},{"key":"2025082120022600800_oeaf078-B119","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1073\/pnas.0400062101","article-title":"Tissue damage in the amyloidoses: transthyretin monomers and nonnative oligomers are the major cytotoxic species in tissue culture","volume":"101","author":"Reixach","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2025082120022600800_oeaf078-B120","doi-asserted-by":"crossref","first-page":"5316","DOI":"10.1002\/ehf2.13621","article-title":"Prognostic value of left atrial strain in patients with wild-type transthyretin amyloid cardiomyopathy","volume":"8","author":"Oike","year":"2021","journal-title":"ESC Heart Fail"},{"key":"2025082120022600800_oeaf078-B121","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jcmg.2021.06.022","article-title":"Clinical importance of left atrial infiltration in cardiac transthyretin amyloidosis","volume":"15","author":"Bandera","year":"2022","journal-title":"JACC Cardiovasc Imaging"},{"key":"2025082120022600800_oeaf078-B122","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/j.jcmg.2023.01.015","article-title":"Prognostic utility of left atrial strain to predict thrombotic events and mortality in amyloid cardiomyopathy","volume":"16","author":"Akintoye","year":"2023","journal-title":"JACC Cardiovasc Imaging"},{"key":"2025082120022600800_oeaf078-B123","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1016\/j.jcmg.2021.01.016","article-title":"Prognostic utility of echocardiographic atrial and ventricular strain imaging in patients with cardiac amyloidosis","volume":"14","author":"Huntjens","year":"2021","journal-title":"JACC Cardiovasc Imaging"},{"key":"2025082120022600800_oeaf078-B124","doi-asserted-by":"crossref","first-page":"4139","DOI":"10.1002\/ehf2.15013","article-title":"Diagnostic and prognostic value of the left atrial myopathy evaluation in cardiac amyloidosis using echocardiography","volume":"11","author":"Ferkh","year":"2024","journal-title":"ESC Heart Fail"},{"key":"2025082120022600800_oeaf078-B125","doi-asserted-by":"crossref","first-page":"133087","DOI":"10.1016\/j.ijcard.2025.133087","article-title":"Prognostic implications of the left atrial stiffness index in patients with cardiac amyloidosis","volume":"426","author":"Gao","year":"2025","journal-title":"Int J Cardiol"},{"key":"2025082120022600800_oeaf078-B126","doi-asserted-by":"crossref","first-page":"e2426086","DOI":"10.1001\/jamanetworkopen.2024.26086","article-title":"National and regional medicare spending on tafamidis, 2019\u20132021","volume":"7","author":"Blatt","year":"2024","journal-title":"JAMA Netw Open"}],"container-title":["European Heart Journal Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ehjopen\/article-pdf\/5\/4\/oeaf078\/63715332\/oeaf078.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjopen\/article-pdf\/5\/4\/oeaf078\/63715332\/oeaf078.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T00:02:58Z","timestamp":1755820978000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ehjopen\/article\/doi\/10.1093\/ehjopen\/oeaf078\/8195997"}},"subtitle":[],"editor":[{"given":"Frank A","family":"Flachskampf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":126,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,7,4]]}},"URL":"https:\/\/doi.org\/10.1093\/ehjopen\/oeaf078","relation":{},"ISSN":["2752-4191"],"issn-type":[{"value":"2752-4191","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,7]]},"published":{"date-parts":[[2025,7]]},"article-number":"oeaf078"}}